Antonio Tito Fojo - Concepedia

Author

Antonio Tito Fojo

Also Known As

A Fojo, A T Fojo, A. Fojo, A. T. Fojo, A. Tito Fojo, A.T. FOJO, A.T. Fojo, A. Tito Fojo, ANTONIO T. FOJO, ANTONIO TITO FOJO

243

Publications

17.9K

Citations

H-Index

114

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health Clinical Center

About

Antonio Tito Fojo is an author at National Cancer Institute specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	49	8.4K
2	Health Sciences	14	15	3.1K
3	Engineering	3	3	785
4	Natural Sciences	2	2	104
5	Public Health	1	1	284

Antonio Tito Fojo

Publications

14.7K

Citations

H-Index

Page 1

	Year	Citations
Expression of a multidrug-resistance gene in human tumors and tissues. Antonio Tito Fojo, Kazumitsu Ueda, Dennis J. Slamon, Proceedings of the National Academy of Sciences PathologyMultidrug ResistanceCancer BiologyTumor BiologyDrug Resistance	1987	1.6K
Expression of Multidrug Resistance Gene in Human Cancers Lori J. Goldstein, Hanan Galski, Antonio Tito Fojo, JNCI Journal of the National Cancer Institute	1989	1.3K
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma Richard Piekarz, Robin Frye, Maria L. Turner, Journal of Clinical Oncology ImmunologyPathologyPharmacotherapyMetronomic ChemotherapyDermatology	2009	728
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Igor B. Roninson, Janice E. Chin, Kyoung‐Gyu Choi, Proceedings of the National Academy of Sciences Molecular BiologyPathologyTumor BiologyDrug ResistanceHamster Mdr Gene	1986	702
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer Kevin C. Conlon, Enrico Lugli, Hugh C. Welles, Journal of Clinical Oncology	2014	686
Human Multidrug-Resistant Cell Lines: Increased <i>mdr</i> 1 Expression Can Precede Gene Amplification Donglai Shen, Antonio Tito Fojo, Janice E. Chin, Science EngineeringMdr1 MrnaCancer BiologyTumor BiologyDrug Resistance	1986	604
Isolation and genetic characterization of human KB cell lines resistant to multiple drugs Shin‐ichi Akiyama, Antonio Tito Fojo, John A. Hanover, Somatic Cell and Molecular Genetics Human CellHealth SciencesCytogeneticsMedicineGenetic Characterization	1985	553
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Victor Sandor, Susan Bakke, Robert W. Robey, PubMed	2002	509
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma Richard Piekarz, Robin Frye, H. Miles Prince, Blood	2011	476
Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Antonio Tito Fojo, Shin‐ichi Akiyama, Michael M. Gottesman, PubMed PathologyCellular PharmacologyPharmacotherapyCancer BiologyTumor Biology	1985	436

Page 1